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BCEA: a R package for Bayesian health economics
What is BCEA not?
• BCEA is not a package to automatically run a Bayesian analysis -It cannot build the health economic model for you -It does not prepare the data to be used in the model -It does not automatically run the MCMC simulations from the posterior distributions of the Bayesian model -It does not choose the prior distributions for you So what is it, then?
• BCEA is a package that provides a set of specific functions to systematically post-process the output of a Bayesian health economic model • Uses R (http://cran.r-project.org/) to achieve this -R is particularly good at interacting with standard MCMC software * BUGS (http://openbugs.net) * JAGS (http://mcmc-jags.sourceforge.net) -R is free and there is a very large community of contributors; it is specifically designed for statistical analysis and has very good graphical capabilities 2 How does BCEA work?
Modelling in health economics
A typical work-flow for a economic evaluation starts with some data pre-processing. This includes creating, aggregating or modifying some original variables (which may be available as individuallevel data or aggregated summaries). This step can be done in a statistical software (e.g. R or Stata), but sometimes less sophisticated options (e.g. MS Excel) may be used. Then, a model is set up, formalising all the distributional assumptions (this is done under both the frequentist and the Bayesian approaches, although perhaps the latter requires a more explicit account). In a Bayesian framework, this step amounts to coding the assumptions on the relevant distributions, for example in a BUGS or JAGS file. Then, the model is run; in a Bayesian framework, this is typically done by using specific software to perform the estimation (usually Markov Chain Monte Carlo, MCMC). It is possible and very often useful to interface the main statistical software (e.g. R) with the MCMC sampler (e.g. BUGS or JAGS). In any case, this step produces the required estimation for the (posterior) distributions of the relevant quantities.
Then, the results are post-processed; this means that the statistical analysis results are combined to define suitable variables of population average costs and clinical benefits (e.g. QALYs), which are the basis of the economic evaluation. Again, this step is done in a statistical software (e.g. R), but sometimes less sophisticated options (e.g. MS Excel) may be used.
Finally, we run the economic analysis, which computes summaries such as the ICER, costeffectiveness (CE) plane and considers Probabilistic Sensitivity Analysis (PSA), for example using the cost-effectiveness acceptability curve (CEAC) and the expected value of information. The decision process is analysed based on these indicators. BCEA only comes into play at this stage!
Using BCEA
Once the suitable variables of cost and effectiveness are available in the R workspace, it is possible to load the BCEA package and then use its functions to obtain all the relevant summaries and graphs for the decision-making exercise.
BCEA can be installed from the central packages repository by typing at the R terminal the command install.packages("BCEA") -assuming an internet connection is available. Once installed, the package can be loaded into the R workspace by typing at the terminal library(BCEA).
Assume that the economic problem at hand consists in the comparison of two interventions t = 0, 1 for which suitable measures of benefits and costs (e, c) have been defined. In a Bayesian framework, these are characterised by samples (e.g. of 1000 simulations) from the posterior distributions, but even in a standard frequentist analysis, it is common to work using bootstrap simulations, so that PSA can be performed. In many health economic models, these are the obtained using a MS Excel spreadsheet -but notice that it is possible to easily import data from a xls file into R; thus BCEA can be used to post-process any economic model (not just a Bayesian one!). We assume that, at this point, the R workspace contains two matrices e,c of size n sim × n int (number of simulations times number of interventions), which are samples from the relevant (posterior) distributions for the benefit and the cost variable. We can now call the function bcea, which performs the basic economic analysis, by typing at the R terminal the command m <-bcea(e,c,ref=2). Here, the option ref=2 instructs R that the second column of e and c contain the data for the reference intervention, while all other columns will have the data for the comparators.
It is possible to specify other options; for instance, we can define a vector labels in which we include the text strings labelling each of the interventions being considered. Thus, typing the command m <-bcea(e,c,ref=2,interventions=labels) instructs R to assign the values in label to name each of the interventions being considered. 
Cost Effectiveness Acceptability Curve
Willingness to pay Probability of cost effectiveness 0 10000 30000 50000 0 100000 250000 The object m contains several elements, which can be then used to produce all the relevant analyses. For example, typing plot(m) produces the graph in the left-most part of Figure 1 , which shows the cost-effectiveness plane and the expected incremental benefit, the CEAC and the EVPI (as functions of the willingness to pay, k). The command summary(m) prints the summary table in the right-most part of Figure 1 .
Expected Value of Information
Other graphical summaries are available; for example, typing contour2(m) produces a contour plot for the CE plane for the default value of k = 25000 monetary units (e.g. £), as in the left-most part of Figure 2 . The optional parameter wtp defines the "sustainability area"; typing contour2(m,wtp=1 ) shows the plot for k = 1000 monetary units (as shown in the right-most part of Figure 2 ).
Cost effectiveness plane New Chemotherapy vs Old Chemotherapy
Effectiveness differential BCEA can easily perform more complex PSA, for instance based on the expected value of partial information. This has been the subject of recent methodological development and BCEA implements the most recent tools. The function evppi can be applied to the object m to obtain a graph showing the relative importance of a set of parameters in determining the overall decision uncertainty, as presented in Figure 3 . 
Expected Value of Perfect Partial Information
Willingness to pay
EVPI (1) EVPPI for c.amb (2) EVPPI for rho (3) EVPPI for gamma (4) EVPPI for pi [1] (5) EVPPI for pi [2] Figure 3. Expected value of partial information using BCEA BCEA can also deal with the situation involving multiple treatment comparisons (e.g. when more than 2 interventions are being assessed). To this aim, two graphical displays can be easily produced, as shown in Figure 4 . Typing the commands m2 <-multi.ce(m) and mce.plot(m2) produces the CEAC for the multiple comparison, showing the probability that each treatment is the most cost-effective, as a function of k (left-most part of Figure 4 ). In addition, the command ceef.plot(m) produces the cost-effectiveness efficiency frontier, shown in the right-most part of Figure 4 . Finally, BCEA can also perform structural sensitivity analysis (assuming two or more competing models and performing some form of model averaging) and PSA assuming risk-aversion in the utility function (extending the standard framework of the monetary net benefit, which implies riskneutrality).
